Alan Fuhrman Insider Trading $ESPR Esperion Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Alan Fuhrman.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Alan Fuhrman. Alan Fuhrman is Senior Vice President & CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in Esperion Therapeutics, Inc. ($ESPR) and Chief Financial Officer in Mirna Therapeutics, Inc. ($MIRN) and Director in Loxo Oncology, Inc. ($LOXO) and Director in SpringWorks Therapeutics, Inc. ($SWTX).

Alan Fuhrman in Esperion Therapeutics, Inc.

Trading Symbol: ESPR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Director
Holdings: 12,878 shares
Current Value: $227,425
Latest Transaction: May 29 2020
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Alan Fuhrman in Esperion Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACHV, ESPR, LOXO, SWTX, SYBX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 29 2020ESPREsperion Therapeut ...Fuhrman AlanDirectorGrantA0.001,221012,87811.7 K to 12.9 K (+10.47 %)
May 18 2020ESPREsperion Therapeut ...Fuhrman AlanDirectorGrantA0.0011,003011,657654 to 11.7 K (+1,682.42 %)

Page:   1